ストックスクリーナーアプリを入手
3.60
0.55%
-0.02
前日終値:
$3.62
開ける：
$3.72
24時間の取引高:
3.48M
Relative Volume:
1.05
時価総額：
$833.24M
収益：
-
当期純損益:
$-179.82M
株価収益率:
-2.7068
EPS:
-1.33
ネットキャッシュフロー:
$-159.16M
1週間 パフォーマンス:
+8.11%
1か月 パフォーマンス:
+33.33%
6か月 パフォーマンス:
+183.46%
1年 パフォーマンス:
+295.60%
1日の値動き範囲:
$3.56
$3.79
1週間の範囲:
$3.34
$3.80
52週間の値動き範囲:
$0.76
$3.80
Gossamer Bio Inc Stock (GOSS) Company Profile
GOSS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
3.60 | 837.87M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-10 | アップグレード | UBS | Neutral → Buy |
| 2025-07-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-25 | 開始されました | Oppenheimer | Outperform |
| 2024-04-05 | 再開されました | Wedbush | Outperform |
| 2023-07-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-03-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | 開始されました | Guggenheim | Neutral |
| 2022-12-07 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-12-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2022-12-07 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | 開始されました | Goldman | Buy |
| 2022-09-21 | 開始されました | JP Morgan | Neutral |
| 2022-09-19 | 開始されました | Wedbush | Outperform |
| 2022-04-18 | 開始されました | Raymond James | Outperform |
| 2022-04-06 | 開始されました | UBS | Buy |
| 2022-01-10 | アップグレード | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | 再開されました | Cantor Fitzgerald | Overweight |
| 2021-09-21 | 再開されました | Piper Sandler | Overweight |
| 2020-06-29 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-22 | 開始されました | Piper Sandler | Overweight |
| 2020-02-27 | 開始されました | Barclays | Overweight |
| 2019-12-03 | 再開されました | BofA/Merrill | Buy |
| 2019-10-30 | 開始されました | Berenberg | Buy |
| 2019-03-05 | 開始されました | Barclays | Overweight |
| 2019-03-05 | 開始されました | BofA/Merrill | Buy |
| 2019-03-05 | 開始されました | Evercore ISI | Outperform |
| 2019-03-05 | 開始されました | SVB Leerink | Outperform |
すべてを表示
Gossamer Bio Inc (GOSS) 最新ニュース
Gossamer Bio (NASDAQ:GOSS) Hits New 1-Year HighTime to Buy? - MarketBeat
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 9, 2025 - BioSpace
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Gossamer Bio Inc (GOSS) is looking forward to a strong quarter - setenews.com
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.9%Still a Buy? - MarketBeat
Is Gossamer Bio Stock Built to Withstand a Pullback? - Trefis
What RSI levels show for Gossamer Bio Inc. (4GB) stockJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
Adversity is less terrifying than hope: Gossamer Bio Inc (GOSS) - setenews.com
Why millennials buy Gossamer Bio Inc. (4GB) stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Will Gossamer Bio Inc. stock maintain growth storyJuly 2025 Patterns & Community Supported Trade Ideas - Newser
How Recent Developments Are Shaping the Gossamer Bio Investment Story - Yahoo Finance
Gossamer Bio, Inc.'s (NASDAQ:GOSS) 28% Share Price Surge Not Quite Adding Up - simplywall.st
Gossamer Bio to Participate in Upcoming December 2025 Investor Conferences - BioSpace
Gossamer Bio to Participate in Upcoming Investor Conferences - Enidnews.com
Analysts Offer Predictions for Gossamer Bio FY2025 Earnings - MarketBeat
GOSS News Today | Why did Gossamer Bio stock go down today? - MarketBeat
How Gossamer Bio Inc. (4GB) stock reacts to fiscal policiesWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
How Gossamer Bio Inc. (4GB) stock moves in volatile trading sessionsMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
What downside risks could hit Gossamer Bio Inc. (4GB) stock2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Volume spikes in Gossamer Bio Inc. stock – what they meanPortfolio Risk Summary & Accurate Trade Setup Notifications - newser.com
Strategies to average down on Gossamer Bio Inc.2025 Trading Recap & Long Hold Capital Preservation Tips - newser.com
Will Gossamer Bio Inc. stock benefit from sector rotationJuly 2025 Short Interest & Low Risk High Reward Ideas - newser.com
Why Gossamer Bio Inc. (4GB) stock could outperform next yearMarket Sentiment Report & Entry Point Confirmation Alerts - newser.com
Is now a turning point for Gossamer Bio Inc.July 2025 Market Mood & Real-Time Stock Movement Alerts - newser.com
Is Gossamer Bio Inc. stock near bottom after declineJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Ranking Gossamer Bio Inc. among high performing stocks via toolsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Why retail investors favor Gossamer Bio Inc. stockTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Why Gossamer Bio Inc. stock remains undervalued2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
What valuation multiples suggest for Gossamer Bio Inc. stockBuy Signal & Community Verified Watchlist Alerts - newser.com
Gossamer Bio Inc (GOSS) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):